- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech High Growth Potential Companies
Taiwanese Pharmaceuticals & Biotech High Growth Potential Companies
Results
5
Companies with a Future performance score of at least 3, ordered by Future performance score.
5 companies
Bora Pharmaceuticals
Market Cap: NT$63.3b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$510.00
7D
-19.8%
1Y
-22.8%
PharmaEssentia
Market Cap: NT$167.7b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$453.50
7D
-9.3%
1Y
-13.8%
Lotus Pharmaceutical
Market Cap: NT$74.2b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$282.00
7D
-2.1%
1Y
-2.1%
Caliway Biopharmaceuticals
Market Cap: NT$208.6b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$134.50
7D
8.5%
1Y
150.5%
ScinoPharm Taiwan
Market Cap: NT$13.4b
Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, the America, and internationally.
1789
NT$17.00
7D
-4.2%
1Y
-28.0%